Can AlphaFold save lives in epidemics?

Recently, Google DeepMind’s AlphaFold again made news, having overwhelmingly won the latest CASP...

CONTINUE READING

My Experience Building a Predictive Model to Limit hERG Liabilities

Since joining Cyclica nearly two years ago, I’ve conducted several R&D projects investigating and...

CONTINUE READING

Raising Capital? My Dos and Don'ts Having Raised ~$40M.

Originally published on LinkedIn: https://bit.ly/3jLgf3L 

At Cyclica, over the past 7+ years, we’ve...

CONTINUE READING

Using Cyclica’s technology to identify repurposed drug candidates for COVID-19

At the time of writing this article, over 1.3 million people have been confirmed to be infected...

CONTINUE READING

Part I: Leadership Lessons: Leading During Uncertainty (a COVID19 motivated article)

Originally published on LinkedIn: https://bit.ly/3BnnNzB

Reflecting on the past four months, many...

CONTINUE READING

Discarding information to make predictions: Thoughts on how to predict drug properties robustly

CONTINUE READING

The Stories of the Phenomenal Women of Cyclica

The Science, Technology, Engineering, and Math (STEM) disciplines are responsible for many...

CONTINUE READING

The Future of Healthcare in Africa: Opportunities for Ecosystem Driven Innovation with AI

Originally posted on LinkedIn: https://bit.ly/3mqQrM7

The purpose of this post is to: i) highlight...

CONTINUE READING

What's the fuss behind polypharmacology & multi-targeted drug design?

Originally posted on LinkedIn: https://bit.ly/3bpyKpG

It is well understood that while the common...

CONTINUE READING

Part II - Facing Failure Head On: What Our Startup Learned From One of Our Biggest Mistakes - Branding

Originally posted on LinkedIn: https://bit.ly/3CubQtp

I am not sure where I heard it first - I...

CONTINUE READING